Shukra Pharmaceuticals Limited (BSE: 524632)
Health Care · Pharmaceuticals · IN
Rs61.84
+10.69% today · +79.5% 1Y
Shukra Pharmaceuticals Limited (BSE: 524632) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $282.36M.
Over the last twelve months the share price has gained 79.5%, trading between 26.30 and 65.40.
Tweenvest scores Shukra Pharmaceuticals Limited across four factors: quality 69/100, value 37/100, growth 100/100, dividend 39/100. Its strongest factor is growth.
524632 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $282.36M
- Revenue (TTM)
- $7.92M
- P/E
- 76.50
- EPS
- 0.81
- Dividend yield
- 0.02%
- Beta (5Y)
- 0.58
- 52-week high
- Rs65.40
- 52-week low
- Rs26.30
- Avg volume (3M)
- —
- Shares outstanding
- 439.61M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fulcrum Therapeutics, Inc.NasdaqGM: FULC | $286.11M | $3.75 | +2.18% |
| Elite Pharmaceuticals, Inc.OTCPK: ELTP | $285.44M | $0.27 | +4.22% |
| BioAge Labs, Inc.NasdaqGS: BIOA | $285.02M | $6.21 | -0.80% |
| Fuji Pharma Co., Ltd.TSE: 4554 | $284.84M | ¥1,720.00 | -6.06% |
| Antibiotice S.A.BVB: ATB | $280.68M | RON2.00 | -0.10% |
| EyePoint, Inc.NasdaqGM: EYPT | $280.19M | $3.46 | +6.46% |
| Pharmasaga Co. Ltd.TPEX: 7878 | $279.83M | NT$166.50 | -8.77% |
| Hikal LimitedBSE: 524735 | $279.37M | Rs218.15 | +0.09% |
Figures last refreshed Oct 4, 2026.